Biological
Closed. Please see Biological100
Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses
13 August 2013
Parent virus Candidate vaccine virus Type of virus or reassortant Developing institute Available from
A/Shanghai/2/2013
Synthetic HA&NA
IDCDC-RG32A* Reverse genetics CDC, USA CDC, USA
NIBRG-267** Reverse genetics NIBSC, UK NIBSC, UK
CBER-RG4A* Reverse genetics CBER, USA CBER, USA
A/Anhui/1/2013 Wild type virus WHO CCs
NIBRG-268* Reverse genetics NIBSC, UK NIBSC, UK
NIIDRG-10.1* Reverse genetics NIID, Japan NIID, Japan
* These viruses are candidate vaccine viruses which have passed relevant safety testing and two-way haemagglutination inhibition (HI) tests. They can be handled under BSL-2 enhanced containment1.
** These are potential candidate vaccine viruses which have passed relevant safety testing and can be handled under BSL-2 enhanced containment1. Full virus characterization is yet to be finished.
1 http://www.who.int/biologicals/areas/vaccines/influenza/biosafety_risk_assessment
Institutes contact details for candidate vaccine viruses orders/information:
CBER: Zhiping.Ye@fda.hhs.gov
CDC: rvd6@cdc.gov
NIBSC: standards@nibsc.org
NIID: nobusawa@nih.go.jp
WHO CCs: http://www.who.int/influenza/gisrs_laboratory/collaborating_centres/list/en/
For general enquiries, please contact gisrs-whohq@who.int
For other candidate vaccine viruses and potency testing reagents, please go to
http://www.who.int/influenza/vaccines/virus/candidates_rea
http://www.who.int/influenza/vaccines/virus/candidates_reagents/summary_a_h7n9_cvv_20130813.pdf
WHO | Candidate vaccine viruses for avian influenza A(H7N9)
http://www.who.int/influenza/vaccines/virus/candidates_reagents/a_h7n9/en/index.html
13 August 2013
Parent virus Candidate vaccine virus Type of virus or reassortant Developing institute Available from
A/Shanghai/2/2013
Synthetic HA&NA
IDCDC-RG32A* Reverse genetics CDC, USA CDC, USA
NIBRG-267** Reverse genetics NIBSC, UK NIBSC, UK
CBER-RG4A* Reverse genetics CBER, USA CBER, USA
A/Anhui/1/2013 Wild type virus WHO CCs
NIBRG-268* Reverse genetics NIBSC, UK NIBSC, UK
NIIDRG-10.1* Reverse genetics NIID, Japan NIID, Japan
* These viruses are candidate vaccine viruses which have passed relevant safety testing and two-way haemagglutination inhibition (HI) tests. They can be handled under BSL-2 enhanced containment1.
** These are potential candidate vaccine viruses which have passed relevant safety testing and can be handled under BSL-2 enhanced containment1. Full virus characterization is yet to be finished.
1 http://www.who.int/biologicals/areas/vaccines/influenza/biosafety_risk_assessment
Institutes contact details for candidate vaccine viruses orders/information:
CBER: Zhiping.Ye@fda.hhs.gov
CDC: rvd6@cdc.gov
NIBSC: standards@nibsc.org
NIID: nobusawa@nih.go.jp
WHO CCs: http://www.who.int/influenza/gisrs_laboratory/collaborating_centres/list/en/
For general enquiries, please contact gisrs-whohq@who.int
For other candidate vaccine viruses and potency testing reagents, please go to
http://www.who.int/influenza/vaccines/virus/candidates_rea
http://www.who.int/influenza/vaccines/virus/candidates_reagents/summary_a_h7n9_cvv_20130813.pdf
WHO | Candidate vaccine viruses for avian influenza A(H7N9)
http://www.who.int/influenza/vaccines/virus/candidates_reagents/a_h7n9/en/index.html